Lynx1 Capital Management LP

Insider Reports History

Entity
Company
Location
151 Calle De San Francisco, Suite 200 Pmb 1237, San Juan, Puerto Rico
Signature
Lynx1 Capital Management LP, By: Lynx1 Capital Management GP LLC, its general partner, By: /s/ Weston Nichols, Sole Member
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Lynx1 Capital Management LP:

Stock Role Class Num Shares Value Price $ Report Date Ownership
TScan Therapeutics, Inc. 10%+ Owner Pre-funded Warrant (right to buy) 7.5M $30M $4.00 Dec 26, 2024 Indirect
TScan Therapeutics, Inc. 10%+ Owner Common Stock 5.36M $15.5M $2.90 Dec 13, 2024 Indirect
Passage BIO, Inc. 10%+ Owner Common stock, $0.0001 par value per share 9.26M $5.97M $0.65 Dec 27, 2024 Indirect

Insider Reports Filed by Lynx1 Capital Management LP

Symbol Company Period Transactions Value $ Form Type Date Filed Role
PASG Passage BIO, Inc. Dec 27, 2024 1 $241K 4 Dec 31, 2024 10%+ Owner
TCRX TScan Therapeutics, Inc. Dec 26, 2024 1 $30M 4 Dec 30, 2024 10%+ Owner
TCRX TScan Therapeutics, Inc. Dec 12, 2024 2 $386K 4 Dec 16, 2024 10%+ Owner
PASG Passage BIO, Inc. Nov 25, 2024 3 $285K 4 Nov 27, 2024 10%+ Owner
TCRX TScan Therapeutics, Inc. Nov 15, 2024 1 $4.11K 4 Nov 19, 2024 10%+ Owner
PASG Passage BIO, Inc. Aug 7, 2024 0 $0 3 Aug 9, 2024 10%+ Owner
TCRX TScan Therapeutics, Inc. Apr 19, 2024 1 $35.6M 4 Apr 23, 2024 10%+ Owner
TCRX TScan Therapeutics, Inc. May 31, 2023 3 -$64K 4 Jun 2, 2023 10%+ Owner
TCRX TScan Therapeutics, Inc. May 31, 2023 0 $0 3 Jun 2, 2023 10%+ Owner